Sporeamicin A is a new erythromycin-type antibiotic isolated from a species of Saccharopolyspora. It was active in vitro against a wide variety of Gram-positive bacteria. In vitro studies indicated that the sporeamicin A was stable in the presence of human serum, although it was bound to serum proteins. Sporeamicin A was effective in the mouse protection test against Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae. Sporeamicin A attained higher plasma and tissue levels in the rat than did erythromycin stearate.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.7164/antibiotics.45.613 | DOI Listing |
J Antibiot (Tokyo)
May 1992
Research Laboratories, Toyo Jozo Co., Ltd., Shizuoka, Japan.
Sporeamicin A is a new erythromycin-type antibiotic isolated from a species of Saccharopolyspora. It was active in vitro against a wide variety of Gram-positive bacteria. In vitro studies indicated that the sporeamicin A was stable in the presence of human serum, although it was bound to serum proteins.
View Article and Find Full Text PDFJ Antibiot (Tokyo)
May 1992
Research Laboratories, Toyo Jozo Co., Ltd., Shizuoka, Japan.
Structure of a novel antibiotic, sporeamicin A (SRM-A), was determined by a combination of spectroscopic and X-ray crystallographic studies. SRM-A has a unique structure containing a 2,3-dihydro-3-oxofuran moiety as part of a 14-membered macrolide ring.
View Article and Find Full Text PDFJ Antibiot (Tokyo)
May 1992
Research Labolatories, Toyo Jozo Co., Ltd., Shizuoka, Japan.
Sporeamicin A, a novel antibiotic, was isolated from the culture filtrate of an actinomycete. The producing organism, strain L53-18, was taxonomically assigned as a species of the genus Saccaropolyspora. The antibiotic was extracted with chloroform and was then purified by crystallization.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!